Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1 8Phase 1/2 3Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 1

Interventions

Blood Specimen Collection 11Radiosurgery 7Sentinel Lymph Node Biopsy 5Early Intervention, Educational 5Surveys and Questionnaires 4Standard of Care 4Practice Guidelines as Topic 4Methods 4Indocyanine Green 4Educational Status 4X-Rays 3Surgical Procedures, Operative 3Nivolumab 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Immunotherapy 3Cognitive Behavioral Therapy 3Biopsy 3pembrolizumab 2montanide ISA 51 2aldesleukin 2Tomography, X-Ray Computed 2Tomography, Emission-Computed 2Specimen Handling 2Radiotherapy 2Radiation 2Positron-Emission Tomography 2Palliative Care 2Observation 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Melanoma × incomplete Freund's adjuvant × Clear all
NCT00006243 2013-01-25

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

National Cancer Institute (NCI)

Phase NA Completed
30 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡